- Home
- MI/ACS
MI/ACS
Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity
- 1.00 European Board for Accreditation in Cardiology (EBAC)
Published:
Learning objectives
- Discuss the current practice gaps in hypercholesterolaemia management
- Recall best practice for assessing CV risk, defining LDL-C targets and offering patient education
- Stratify patients by CV risk category
- Select cholesterol-lowering therapies according to risk category and LDL-C target
Incretin Management in Type 2 Diabetes
- 1.00 EBAC
Published:
Learning objectives
- Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
- Identify underlying facets of clinical inertia in T2DM care
- Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
- Recall efficacy & the mode of action of various incretin-based treatments
- Adopt an early, intensive glucose-lowering strategy in appropriate individuals
- Select appropriate incretin treatment & dosing regimens according to patient profiles
- Identify individuals likely to gain cardiovascular benefit from GLP-1RAs
- Select appropriate actions following adverse events from incretin-based treatments
P2Y12 Receptor Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndrome Patients
- 1.00 EBAC
Published:
Learning objectives
- Recall the supportive evidence underpinning recommended antiplatelet approaches in individuals with unknown coronary anatomy, including choice of therapy, duration, timing and loading doses
- Compare the design of different clinical trials that have influenced antiplatelet therapy choice in NSTE-ACS patients who proceed to PCI
- Apply trial data and clinical guidelines on the use of antiplatelet therapy in patients undergoing revascularisation to a surrogate patient case
TIO 2020 – CHIP Live Cases
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
TIO 2020 – Focus on Calcified Lesions
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
TIO 2020 – Technologies and Controversies
- 1.00 EBAC
Published:
Learning objectives
- Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
- Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
- Assess the merits of adopting emerging technologies within their practice
- Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
- Interact with opinion leaders in their profession
